Drugs Information: Bretylium

Basic Information

ID DDInter229
Drug Type small molecule
Molecular Formula C11H17Brn
Molecular Weight 243.168
Description Bretylium is a norepinephrine release inhibitor used for the prophylaxis and therapy of ventricular fibrillation, as well as the treatment of life-threatening ventricular arrhythmias.
ATC Classification C01BD02
IUPAC Name [(2-Bromophenyl)Methyl](Ethyl)Dimethylazanium
InChI Inchi=1S/C11H17Brn/C1-4-13(2,3)9-10-7-5-6-8-11(10)12/H5-8H,4,9H2,1-3H3/Q+1
Canonical SMILES CC[N+](C)(C)CC1=CC=CC=C1Br
Useful Links DrugBank ChEMBL PubChem

Interactions with Bretylium

Severity level ID Name Mechanism Detail